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ABSTRACT
Objective To examine the effectiveness and cost-
effectiveness of group therapy for self harm in young
people.
Design Two arm, single (assessor) blinded parallel
randomised allocation trial of a group therapy
intervention in addition to routine care, compared with
routine care alone. Randomisation was by minimisation
controlling for baseline frequency of self harm, presence
of conduct disorder, depressive disorder, and severity of
psychosocial stress.
Participants Adolescents aged 12-17 years with at least
two past episodes of self harm within the previous
12 months. Exclusion criteria were: not speaking English,
low weight anorexia nervosa, acute psychosis,
substantial learning difficulties (defined by need for
specialist school), current containment in secure care.
SettingEightchildandadolescentmentalhealthservices
in the northwest UK.
Interventions Manual based developmental group
therapy programmespecificallydesignedfor adolescents
who harm themselves, with an acute phase over six
weekly sessions followed by a booster phase of weekly
groups as long as needed. Details of routine care were
gathered from participating centres.
Main outcomemeasures Primary outcome was frequency
ofsubsequentrepeatedepisodesofselfharm.Secondary
outcomes were severity of subsequent self harm, mood
disorder, suicidal ideation, and global functioning. Total
costs of health, social care, education, and criminal
justice sector services, plus family related costs and
productivity losses, were recorded.
Results183adolescentswereallocatedtoeacharm(total
n=366).Losstofollow-upwaslow(<4%).Onalloutcomes
the trial cohort as a whole showed significant
improvement from baseline to follow-up. On the primary
outcome of frequency of self harm, proportional odds
ratio of group therapy versus routine care adjusting for
relevant baseline variables was 0.99 (95% confidence
interval0.68to 1.44, P=0.95) at 6months and0.88(0.59
to 1.33, P=0.52) at 1 year. For severity of subsequent self
harm the equivalent odds ratios were 0.81 (0.54 to1.20,
P=0.29) at 6 months and 0.94 (0.63 to 1.40, P=0.75) at
1year.Total1yearcostswerehigherin thegrouptherapy
arm (£21781) than for routine care (£15372) but the
difference was not significant (95% CI −1416 to 10782,
P=0.132).
Conclusions The addition of this targeted group therapy
programme did not improve self harm outcomes for
adolescents who repeatedly self harmed, nor was there
evidenceofcosteffectiveness.Theoutcomestoendpoint
for the cohort as a whole were better than current clinical
expectations.
Trial registration ISRCTN 20496110
INTRODUCTION
Self harm in adolescents is a major public health pro-
blem in many countries. It is associated with recurrent
psychosocial problems
12 and poor long term
outcome,
3 and it may mark an emerging personality
disorder.
4 Self harm tends to recur; the reported risk
of repetition in adolescents ranges from 10% within
six months to 42% during a 21-month follow-up, with
a median recurrence of 5-15% each year.
5 The risk of
suicide after self harm in adolescence is around 0.1-
0.5% over 10 years
26with retrospective studies report-
ing a repetition rate of 36% over 10-12 years
7 and life-
time mortality rates of 4-11%.
89 Self harm shows
comorbidity with axis I psychiatric disorders in 43%
to 70% of cases, with evidence that the number of
comorbid conditions is associated with increased risk
of a serious suicide attempt.
10 Around two thirds of
children and adolescents presenting with self harm





of major depressive disorder predicts substantially
increased risk of further self harm in young adulthood
when other factors are controlled.
19 The incidence of
self harm is increasing in some areas of the UK.
20
Self harming adolescents contribute substantially to
the workload of healthservices,in termsof both emer-
gencyriskassessmentandlongertermmanagement.A
further substantial burden is placed on wider social
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young person commonly presents to an accident and
emergency department; current National Institute for
Health and Clinical Excellence (NICE) guidance
1 for
England and Wales is for overnight medical hospital
admission as a minimum response and more lengthy
medical or psychiatric admission is often needed in
situations of risk or more severe disorder. A follow-
up study of young adults who had deliberately poi-
soned themselves as adolescents
21 found that their life-
time service costs were significantly greater than those
ofmatchedcontrols.Theyusedmoreserviceprovided
accommodation, special education, and hospital ser-
vices, incurred greater criminal justice costs, and
received more social security benefits.
Despite this large burden, very little is known about
the cost-effectiveness of interventions.
22 In one of the
few studiesto date, Byfordand colleagues
23 undertook
a cost-effectiveness analysis of a home based social
work intervention for children and adolescents who
deliberately poisoned themselves. They found no sig-
nificantdifferencesbetweenthetwogroupsintermsof
themainoutcomemeasuresorcosts,althoughinasub-
group of children without major depression, suicidal
ideation was significantly lower in the intervention
group at follow-up with no significant differences in
cost.
The design and delivery of effective treatments for
thisgrouparecomplexandhavetoaccommodatecon-
siderable variations in presentation.
1 A subgroup of
patients needs emergency inpatient management; the
majorityrequirelongtermtreatmentapproachesinthe
context of multi-agency partnerships. A Cochrane
review of psychosocial and pharmacological treat-
ments for self harm
24 found continuing uncertainty
about which forms of treatment are most effective
and insufficient evidence against which to make firm
recommendations. Across all age ranges, a promising
additional benefit over standard care was found for
problem solving therapy (summary odds ratio across
five studies 0.70; 0.45 to 1.11) and provision of an
emergency contact card (summary odds ratio across
two studies 0.45; 0.19 to 1.07), but neither of these
results reached statistical significance. The authors
noted a number of key limitations across all studies
reviewed. These included insufficient sample sizes,
leading to possible type 2 errors in effectiveness esti-
mates;lackofadequatedescriptionoftheservicesused
as comparison groups; and use of service data (usually
further hospital attendance) rather than interview data
to define the primary outcome of repetition, which
could introduce biases in outcome estimates, owing




24 noted that only two of the
studies reviewed focused on adolescent self harm,
despite the importance of the problem in this age
group and the likelihood that the treatment needs of
adolescentsdifferfromthoseofadults.Trialsofadoles-
centfocusedtreatmentsarethereforeofhighpriorityto
inform service provision. Harrington and colleagues
15
tested a brief family intervention for adolescents (total
n=149)againststandardaftercareandfoundnosignifi-
cant effect on repetition (odds ratio 1.02; 95% CI 0.41
to 2.5; P=0.97). The same group then undertook a
developmental group psychotherapy programme
designed to focus on the multiple clinical problems
typical in this population (depression, experience of
abuse, behavioural disorder, substance misuse, poor
self esteem and body image, and family conflict and
disruption)andtocombineeffectivelywithotherinter-
ventions (pharmacotherapy, individual and family
therapies) using a group therapy format that was cost-
effective of clinician time. A pilot randomised trial of
developmental group psychotherapy compared with
routine care in 63 adolescents referred with repeated
self harm to child and adolescent mental health
services
25 showed a significant relative reduction of
repeated self harm over 29 weeks of follow-up (2/31
in developmental group psychotherapy versus 10/31
inroutinecare;oddsratio6.3;95%CI1.4to28.7).The
totalnumberofselfharmepisodesperparticipantdur-
ing follow-up was also lower for the treatment group
(mean 0.6) than for the routine care group (mean 1.8),
but this difference was not statistically significant. This
trial was one of the few to have suggested effectiveness
of an intervention in patients of any age. A replication
in northern Australia, with remote supervision from
theUKdevelopingteam(n=72)
26failedtoshowatreat-
ment effect. This study, however, recruited from gen-
eral referrals to child and adolescent mental health
services where patients were identified to have self
harming behaviour, rather than from specific self
harm referrals, and it only recruited 57% of its target
for analytical power.
TheAssessmentofTreatmentInSuicidalTeenagers
(ASSIST) trial reported here was intended as a defini-
tivetestofthisgroupinterventionusinga largesample
withapragmaticdesignandincludingadetailedhealth
economic evaluation. Our objective was to use a large
parallel group randomised trial to compare the effec-
tivenessandcost-effectivenessofdevelopmentalgroup
psychotherapy plus routine care with that of routine
care alone for adolescents presenting with repeated
self harm in the previous year. We addressed some of
the methodological weaknesses in previous studies
identified by Hawton and colleagues
24 by recruiting a
large cohort size, making detailed description of rou-
tine treatmentundertaken, and triangulating two inde-
pendentinterviewbasedascertainmentsoftheprimary




Participating centres were established child and ado-
lescent mental health services teams in the northwest
of England, who served substantial geographical areas
and were experienced in the assessment and manage-
ment of young people with self harm. They delivered
RESEARCH
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ship with the ASSIST research team.
Participantswereadolescentsagedbetween12years
and16years11monthswhohadpresentedwithtwoor
more episodes of self harm during the previous
12 months. In the context of this study “self harm”
was deemed to include the non-accidental overdose
of drugs or other toxic substances, or non-accidental
self inflicted injuries such as scratching, cutting, burn-
ing,orstrangulation.Exclusioncriteriawerenon-Eng-
lish speakers, severe low weight anorexia nervosa,
currentpsychoticillness,attendanceatspeciallearning
disability school, current containment in secure care
(young people in other forms of looked after care
such as adoption, fostering, or non-secure residential
units were, however, included).
Interventions
Experimental treatment
Developmental group psychotherapy was a manual
based treatment specifically designed for self harming
adolescents.
25 The programme integrated techniques
from a number of other therapies that have previously
been applied to depressed or suicidal adolescents and
their families, including cognitive behavioural ther-
apy, dialectical behavioural therapy, and group
psychotherapy.
152728 Group goals were oriented
around themes that previous research suggested were
important in adolescents who harm themselves, such
as poor peer relationships, bullying, and family pro-
blems. Adolescents learned strategies to deal with
these difficulties using group based techniques such
as role play. The groups had a rolling entry; young
people started attending as soon as their initial assess-
ment and randomisation were completed and atten-
dance continued until the young person felt ready to
leave.Therapistshadaminimumofthreeyearsofrele-
vantpost-qualifyingexperience.Theyhadinitialtrain-
ing in fidelity to the model from AJW and GT (the
original developers of the intervention), who also led
subsequentregularsupervision,comprisingurgenttel-
ephone consultation during working hours and atten-
dance at a monthly supervision group. In the base site,
developmental group psychotherapy was provided by
AJW and GT and included patients considered clini-
cally challenging by other teams. All clinical groups
were audiotaped or videotaped unless consent was
withheld. Protocol adherence was measured at each
centre from videotaped sessions (minimum four per
site per year; total n=32) by experts independent of
the therapy or training and blind to centre allocation.
Theyusedamodificationforgroupworkofastandard
quality scale for cognitive behavioural therapy.
29
Routine care
Local child and adolescent mental health services
teams provided standard routine care according to
their clinical judgment. By agreement, centres
excluded any group intervention from routine care
during the trial. Non-blinded research staff recorded
the nature and intensity of the routine care delivered
for each case during monthly telephone reviews with
responsible clinicians. Local therapists delivering the
group intervention were not involved with patients
allocated to routine care except in emergencies.
There was careful discussion with local teams regard-
ingtheavoidanceofanycontaminationfromthegroup
treatment into routine care.
Outcomes
Theprimaryoutcomewasthefrequencyofepisodesof
self harm over a defined period (12 months before
baseline, 6 months before 6 month assessment,
6 months before end point). Research assessors, blind
to treatment allocation, conducted a face to face inter-
view with participants every three months from base-
line, using a self harm interview schedule validated in
previous studies.
1215 Structured interviewing techni-
ques were used to minimise recall bias towards more
recent events and to get a profile of the pattern of self
harm over the period. To further reduce recall and
reportingbiases,non-blindedresearchtherapistsinde-
pendentlyconductedanadditionalmonthlytelephone
interview with participant and family using the same
schedule. These two assessments were conferenced
with a senior supervisor, blinded to the case and the
assessment point of the interview, and a consensus rat-
ingwasmadetoactasthetrial’sprimaryoutcome.The
two assessments were also later analysed to look for
systematic bias; none was found.
Secondary outcomes
Severityofselfharmwasevaluatedblindfromtriangu-




sical sequelae, including extended hospital admission.
Mood disorder was assessed with the Mood and
Feelings Questionnaire (MFQ)
30, a 34 item self report
questionnaire to measure depressive symptoms. The
instrumentwasdesignedtoassessthedepressivesymp-
tomareasspecifiedintheDiagnosticandStatisticalMan-
ual of Mental Disorders IV (DSM-IV) for major
depressive disorder. A cut off of 28/29 discriminates
between adolescents with major depression and those
with sub-threshold depression or with no depressive
disorder.
31 The maximum score is 68.
Suicidal ideation was measured with the Suicidal
Ideation Questionnaire (SIQ).
32 This self report ques-
tionnaire,consistingof30 itemsrated0-6,capturesthe
frequency of suicidal thoughts. A high score of 6 indi-
cates numerous and regular suicidal thoughts; 0 indi-
cates that no such thoughts have occurred. Scores
greater than 40 indicate substantial suicidal ideation.
Global functioning was measured using the Health
of the Nation Outcome Scales for Children and Ado-
lescents (HoNOSCA),
33 a semi-structured interview,
which was completed by the blinded research assessor
on the basis of accounts taken directly from the infor-
mant and parents or carers. It measures a broad range
of outcomes on 13 subscales (including emotional
RESEARCH
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school attendance problems, and peer relationships).
Each subscale is interviewer rated on a five point
scale (total score range 0 to 52). The higher the score,
the greater the overall impairment in terms of mental
health difficulties and social functioning. The instru-
menthasbeenwidelyusedinchildandadolescentpsy-
chiatryservicesandisofknownreliabilityandvalidity.
It is sensitive to changes in mental state and psychoso-
cial functioning over brief periods of time.
3334
Economic evaluation
We undertook a cost-effectiveness analysis to answer
the stated aims of the evaluation. A broad perspective
wastaken,includingcoststohealth,socialcare,educa-
tion, and criminal justice sectors. Costs of travel to
intervention appointments and productivity losses to
parents associated with their child’s illness were
reported separately in a sensitivity analysis to explore
the economic impact on families. Data were collected
at baseline and at six and 12 months’ follow-up using
the Child and Adolescent Service Use Schedule (CA-
SUS) developed in previous Child and Adolescent
Mental Health Services trials
233536 and adapted to
ensureallrelevantserviceswereincluded.Atbaseline,
the schedule was used to obtain data for the previous
six months. At six and 12 months’ follow-up, it
recorded data since the previous interview. Inpatient
stays were known to be a key cost driver in child and
adolescent mental health populations,
37 so local
National Health Service Trust hospital records were
searched to ensure the accuracy of data about admis-
sionandlengthofstay.Attendanceatinterventionses-
sions was recorded by study therapists to ensure
accuracy and the blindness of the researcherassessors.
All unit costs (in pounds sterling) were for the finan-
cial year 2005-6, the most recent financial year over
which study data were collected. Discounting of costs
and benefits was not necessary owing to the 12-month
timescale of the study. Intervention sessions were
costed on the basis of the salary of the trial therapist
plus overhead costs (administrative, managerial, and
capital). Calculation of indirect therapist time, includ-
ing preparation and supervision, was based on infor-
mationprovidedbythetrialtherapists.Unitcostsofall
health, social care, education, and criminal justice sec-
tor services were taken from routine sources and were
adjusted to reflect local costs wherever possible.
38-48
Travel costs were self reported return fares or esti-
mated motoring costs per hour.
49 Productivity losses
of the time parents took off work because of their







frequency of self harm was possible as a result of the
developmental group psychotherapy intervention. A
separate survey of child psychiatrists in the UK North
West National Health Service region estimated that a
reductionofa thirdinfrequencyofself harmwould be
theminimumclinicallyimportantdifference.Basedon
this more conservative 33% target reduction in the
numbersofselfharmepisodesbetweendevelopmental
group psychotherapy intervention and control, 312
cases (a 370 target allowing for 15% case attrition)
were estimated to be necessary to achieve 80% power
to detect this difference at the 5% level of significance
with a Mann-Whitney (two sided) test for categorical
data.ThiscalculationwasdonewithnQueryAdvisor
51
software with the frequency distribution derived from
the pilot study. For the routine care group we used the
frequency distribution of the routine care group of the
pilot study and for the intervention group the fre-
quency distributions of the routine care and develop-
mental group psychotherapy intervention were
weighted to give a rate ratio of 2/3, which corresponds
to a proportional odds ratio of approximately 50% for
this distribution.
Randomisation
Randomisation was by remote telephone to the trial
centre at Christie Hospital Manchester. Therapists
completed an eligibility checklist, obtained written
consent, and emailed the checklist to the randomisa-
tion centre. Allocation was by minimisation control-
ling for: high or low self harm (or ≥4 episodes <4
episodes over the previous 12 months); presence of
behavioural disorder (conduct disorder, oppositional
defiant disorder, attention-deficit/hyperactivity disor-
der)ordepressivedisorderonstandardisedpsychiatric
interview(thescheduleforaffectivedisordersandschi-
zophrenia for school aged children: present and life-
time version
52); and presence or absence of high
psychosocial risk (indexed from baseline interview by
presenceofsocialworkerinvolvement,local authority
accommodation,orchaoticlifestyle).Table 1presents
details. Variables included in the minimisation were
chosen as likely to predict treatment response on the
basis of previous published work.
Allocation concealment
The main outcomes were recorded by outcome asses-
sors blinded to treatment allocation. Patients and par-
ents were asked before the interview with the assessor
nottorevealanythingabouttreatment.Theresearcher
never entered the building when treatments were
being run. Assessor guesses of allocation following
end point were no better than chance. All assessment
interviews were audiotaped and a random sample re-
rated by an independent assessor blind to treatment
allocation.Itwasnotpossibletoblindcliniciansinpar-
ticipating centres or the participants themselves to
treatment allocation.
Statistical methods
All analyses were carried out using Stata Statistical
Software Release 9.









gories defined as none, less than once per month, less
than once per fortnight, less than once per week, once
or more per week, twice or more per week, and most
days. The treatment effect for the primary outcome
was estimated using the proportional odds model.
This model estimates the treatment effect as the odds
ratio of a patient being in a category of more frequent
self harm and allows adjustment for baseline covari-
ates. These were treatment centre, sex, and baseline
age, frequency, severity and risk of self harm, psycho-
socialrisk,behaviouraldisorder,anddepressivedisor-
der as prespecified in the statistical analysis plan and
approved by the trial steering committee. In view of
the difficulties with the interpretation of the propor-
tionaloddsratio,whichisgreaterthanthecorrespond-
ing rate ratio, we added an additional analysis related
to the ratio of number of events between treatment
arms. The ratio of the geometric mean number of
days with deliberate self harm was approximated by
log transforming the data for number of days using (1
+ number of self harming events). As the transformed
data were still strongly skewed we estimated confi-
dence intervals using a non-parametric bootstrap.
Severity of self harm at follow-up, categorised as
none, mild, moderate, and severe, was also analysed
usingaproportionaloddsmodel.Thismodelestimates
the treatment effect as the odds ratio of a patient being
inacategoryofmorefrequentormoresevereselfharm
and allows adjustment for baseline covariates, which
were prespecified in the statistical analysis plan
approved by the trial steering committee. Deliberate
self poisoning at follow-up was analysed using logistic
regression. Other secondary outcome measures
(scoresonMoodsandFeelingsQuestionnaire,Suicidal
Ideation Questionnaire, Health of the Nation Out-
come Scales for Children and Adolescents)
303233 were
analysed using analysis of covariance. The first repeti-
tion of self harm was modelled using a proportional
hazards model. Three planned subgroup analyses
werecarriedouttotestforpossibleinteractionbetween
(1) antisocial symptoms, (2) depressive disorder, and
(3) deliberate self poisoning for the primary outcome.
Total costs between groups at 12 months’ follow-up
were compared using standard t tests, with ordinary
least squares regression for adjusted analysis, and the
resultsconfirmedusingnon-parametric,biascorrected
bootstrapping
54 in order to make inferences about the
arithmetic mean.
55 One way sensitivity analyses were
undertaken to explore the sensitivity of the results to
changes in assumptions: intervention costs were recal-
culated using the expected therapist salary scale for
rollout into routine National Health Service practice
(mid-point of the Agenda for Change grade 6); high
cost outliers were excluded; parental travel costs and
productivity losses were added to provide a broader
cost perspective; and single imputation using multiple
regression was used for missing cases.
Cost-effectiveness was explored at 12 months in
terms of the proportion of young people who had not
selfharmedovertheprecedingsixmonths,ratherthan
the categorical primary outcome measure, frequency
of self harm. Economic evaluation requires measures
of effect with interval properties in order to draw con-
clusions about a move from one unit of effect to
another. Categorical variables, where the interval
between different categories is not meaningful or con-
sistent,cannotsupportsuchanapproach.Usingamea-
sure of the proportion of the population who had self
harmedisalsoconsistentwithpreviousstudies.
56Non-
parametric bootstrapping from the costs and effective-
ness data was used to generate a joint distribution of
incremental mean costs and effects for group therapy
and routine care.
54 These distributions were used to
calculate the probabilitythat group therapyis the opti-
mal choice, subject to a range of possible maximum
values (ceiling ratio) that a decision maker might be
willing to pay for a unit improvement in outcome.
57
The ceiling ratio was varied to explore uncertainty in
willingness to pay.
The study received ethical approval from the UK




The flow of participants through the study is outlined
infigure1.Eightcentresparticipatedandeachcontrib-
uted between 18 and 135 patients between August
2002 and August 2006. Follow-up analyses were
done at a mean of 202 days (SD 33.5) and 377 days
(SD 31.3) after randomisation. Pattern of recruitment
and treatment by centre is shown in table 1.
Allocated to developmental group
  psychotherapy (n=183):
    Received group therapy (n=144)
    Did not receive group therapy (defined as ≤4
      sessions) (n=39):
        Moved to secure unit (n=1)
        Symptom remission (n=2)
        Parents stopped young person attending (n=2)
        Other (n=34)
Allocated to routine care (n=183):
  Received routine care (n=115)
  Did not receive routine care (≤4 sessions) (n=68):
    Discharged or lost from service follow-up (n=68)
Lost to follow-up (n=3):
  Unable to trace (n=3)
Lost to follow-up (n=4):
  Unable to trace (n=4)
Assessed for eligibility (n=402)
Randomised (n=366)
Included in ITT analysis (n=180)
None excluded
Included in ITT analysis (n=179)
None excluded
Excluded (n=36):
  Did not meet inclusion criteria(n=8)
  Declined consent (n=27)
  Other reasons (n=1)
Fig 1 | ASSIST study profile. ITT=intention to treat
RESEARCH
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Developmental group psychotherapy was delivered
per protocol in each treatment centre. Mean number
ofgroupsessionsattendedwas10.2(SD10.1):144/183
(79%) patients attended four or more sessions, the
threshold set for treatment adherence (24/183 (6.7%)
attendednosessions,56/183(15.7%)1-3sessions,112/
183 (31.5%) 4-11 sessions, 92/183 (25.8%) 12-25 ses-
sions, 72/183 (20.2%) 26 or more sessions). There
was no evidence of systematic difference between
session lengths or treatment frequency between parti-
cipating centres (Kruskal-Wallis P=0.57). Number of
sessions of routine care was balanced well between
trial arms, with a mean 9.7 (SD 10.4) sessions attended
intheroutinecarearmand8.5(SD11.2)sessionsinthe
group therapy arm. The proportion of early dropout
from routine care is typical in this clinical context;
developmental group psychotherapy, however,
showed significantly less early dropout (39/183
patients) than routine care (68/183 patients;
P<0.0009, fig 1).
Baseline data
Table 1 contains a summary of baseline data. The
groups were well matched on key variables.
Numbers analysed
We substantially exceeded the target recruitment of
n=312derivedfromthepowercalculation.Forthepri-
mary outcome, we analysed data for 364 patients
(group therapy 181, routine care 183) under intention
totreatforfrequencyofself harmand 365(groupther-
apy 182, routine care 183) for severity of self harm
(table 2). Equivalent numbers for the other secondary
outcomes are shown in table 3.
Outcomes and estimation
Primary outcome
The cohort as a whole showed significant improve-
ment from baseline to follow-up. At baseline 94/364
patients self harmed with a frequency of weekly or
more often; at six months the proportion had fallen to
56/364andatoneyearto28/364cases.Atsixmonths,
20% (75/362) showed no self harm and this increased
to 40% (145/357) at one year. The proportion of
patientsdefinedasat“severerisk”(morethanfourepi-
sodes) fell from 33% (121/365) at baseline to 13% (46/
365)atsixmonthsand7%(24/365)atoneyear.Within
this overall improvement, however, we noted no sig-
nificantadded advantage of group treatment over rou-
tinecare.Theproportionaloddsratioofgrouptherapy
compared to routine care, adjusting for prespecified
baseline variables (treatment centre, sex, age, fre-
quency and severity of self harm risk, social impair-
ment, level of behavioural disorder and depressive
disorder) was 0.99 (CI 0.68 to 1.44, P=0.95) at six
months and 0.88 (0.59 to 1.30, P=0.52) at one year for
frequencyof self harm,which doesnot indicatea clini-
cally important benefit, since neither confidence inter-
val includes 0.5. The approximate ratio of the
geometric means of group treatment compared with
routine care was 1.01 (95% CI 0.80 to 1.29, P=0.91) at
six months and 0.94 (0.73 to 1.18, P=0.60) at
12months.Atneitherpointdidtheconfidenceinterval
include the third reduction in ratio of numbers of
events between group therapy and routine care on
which the power calculation was based. We therefore
conclude that there is little evidence of additional ben-
efit of group therapy over routine care. When a treat-
ment allocation with site interaction was added to the




Age at entry into study
12 to 14 years 70 (38%) 69 (38%)
15 to 17 years 113 (62%) 114 (62%)
Male 21 (11%) 21 (11%)
Black and ethnic
minority
11 (6%) 12 (7%)
Site
1 69 (38%) 64 (35%)
2 17 (9%) 17 (9%)
3 15 (8%) 26 (14%)
4 17 (9%) 15 (8%)
5 20 (10%) 20 (11%)
6 26 (14%) 24 (13%)
7 12 (6%) 7 (4%)
8 7 (3%) 10 (6%)
Self harm in past year
Frequency (days*)
≤quarterly (1 to 4) 35 (19%) 27 (15%)
<o n c eam o n t h( 5t o
11)
34 (19%) 38 (21%)
< once a fortnight (12
to 25)
32 (18%) 37 (20%)
< once a week (25 to
51)
36 (20%) 31 (17%)
≥ once a week (52 to
103)
23 (13%) 21 (12%)
≥twiceaweek(104to
182)
17 (9%) 15 (8%)
Most days (182 to
365)




Severity of self harm
Mild problem 58 (32%) 58 (32%)
Marked problem 66 (36%) 62 (34%)
Severe problem 59 (32%) 62 (34%)
Type of self harm
Self poisoning only 5/183 (2.7%) 0
Self harm only 67/183 (37%) 67/181 (37%)
Combined 111/183 (61%) 114/181 (63%)
High psychosocial risk
Absent 126 (69%) 125 (68%)
Present 57 (31%) 58 (32%)
Depressive disorder 112 (61%) 115 (63%)
Behavioural disorder 63 (34%) 59 (32%)
*Number of days with self harm.
†Approximate geometric mean number of self harm events.
RESEARCH
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ment effect between sites for self harm frequency and
severity.
The median time to the first repetition of self harm
post-randomisation in the group treatment arm was
37 days (interquartile range 15 to 123 days) and in the
routine care arm 49 days (17 to 184 days); hazard ratio
1.07 (95% CI 0.85 to 1.34, P=0.58).
Secondary outcomes
Forseverityofselfharm,theproportionaloddsratioof
group therapy compared with routine care adjusting
for pre-specified baseline variables was 0.81 (95% CI
0.54to1.20,P=0.29)atsixmonthsand0.94(0.63to40,
P=0.75) at one year. At baseline 63% (230/364) of
patients were self poisoning. By six months this pro-
portion had reduced substantially; 25% (45/181)
receiving group therapy had self poisoned compared
with 27% (48/181) in the routine care arm (adjusted
odds ratio 0.80, 95% CI 0.48 to 1.35, P=0.41). At
12 months 16% (28/179) receiving group therapy had
self poisoned compared with 15% (27/180) in the rou-
tine care arm (adjusted odds ratio 0.97, 95% CI 0.53 to
1.77, P=0.92).
On other secondary measures there was also an
overall cohort improvement through the trial. Mood,
suicidality, and social functioning improved (Mood
and Feelings Questionnaire by 14 points in usual care
and 16.6 points in group treatment; Suicidal Ideation
Questionnaire by 33 points in usual care, 43 points in
grouptreatment;HealthoftheNationOutcomeScales
forChildrenandAdolescentsscoredroppingbymean
5 points in usual care and 6.6 points in group treat-
ment). There was however no significant relative dif-
ference in improvement between the groups (adjusted
treatment effect for Mood and Feelings Questionnaire
−1.45, Suicidal Ideation Questionnaire −2.37, Health
of the Nation Outcome Scales for Children and Ado-
lescents −0.79; all non-significant).
Table 2 |Frequency and severity of self harm at baseline and follow-up
0-6 months 6-12 months
Routine care Group therapy Routine care Group therapy
Frequency
nn =181 n=181 n=180 n=179
Numberofdaysofself
harmduringtheperiod
0 (none) 39 (21.5, 100.0) 36 (19.9, 100.0) 70 (38.9,100.0) 75 (41.9, 100.0)
1-2(≤ quarterly) 42 (23.2, 78.5) 45 (24.9, 80.1) 46 (25.6, 61.1) 36 (20.1, 58.1)
3-5 (< once a month) 28 (15.5, 55.2) 22 (12.2, 55.2) 21 (11.7, 35.6) 21 (11.7, 38.0)
6-12 (< 1 a fortnight) 26 (14.4, 39.8) 33 (18.2, 43.1) 16 (8.9, 23.9) 22 (12.3, 26.3)
13-25(<onceaweek) 19 (10.5, 25.4) 16 (8.8, 24.9) 11 (6.1, 15.0) 13 (7.3, 14.0)
26-51 (≥ once a
week)
13 (7.2, 14.9) 13 (7.2, 16.0) 10 (5.6, 8.9) 4 (2.2, 6.7)
52-91 (≥ twice a
week)
9 (5.0, 7.7) 11 (6.1, 8.8) 3 (1.7, 3.3) 4 (2.2, 4.5)
92-182 (most days) 5 (2.8, 2.8) 5 (2.8, 2.8) 3 (1.7, 1.7) 4 (2.2, 2.2)
Approximate
geometric mean
number of self harm
events
4.4 4.6 2.1 2.0
Proportional odds
ratio* (95% CI), P









0.94 (0.73 to 1.18),
P= 0.60
Severity
nn =181 n=181 n=180 n=178
No problem 40 (22.1, 100.0) 37(20.4, 100.0) 70 (38.9, 100.0) 75 (42.1, 100.0)
Mild problem 79 (43.7, 77.9) 96 (53.0, 79.6) 76 (42.2, 61.1) 68 (38.2, 57.9)
Marked problem 37 (20.4, 34.3) 27(14.9, 26.5) 21 (11.7, 18.9) 24 (13.5, 19.7)
Severe problem 25 (13.8, 13.8) 21(11.6, 11.6) 13 (7.2, 7.2) 11 (6.2, 6.2)
Proportional odds
ratio * (95% CI), P
0.81 (0.54 to 1.20),
P=0.29
0.94 (0.63 to 1.40),
P=0.75
Data are frequency (%, % greater than or equal to each level) unless otherwise stated.
*Proportional odds ratio of group therapy compared with routine care adjusted for treatment centre, sex,
baseline age, frequency and
severity of self harm, harm risk, psychosocial risk, behavioural disorder, and depressive disorder. Values below
1 represent a less adverse outcome for group therapy compared with routine care.
†Ratio of geometric mean numbers of events for group therapy compared with routine care adjusted for
treatment centre, sex, baseline age, frequency, severity, and risk of self harm, psychosocial risk, behavioural
disorder, and depressive disorder. Values below 1 represent a less adverse outcome for group therapy
compared with routine care.
Table 3 |Summary of secondary outcome measures by time point and treatment group
Routine care Group therapy Difference*
Mean (SD), range n Mean (SD), range n Effect (95% CI) P
HoNOSCA† †
Baseline 16.8 (5.8), 1-40 183 17.5 (5.7), 1-32 181
6 months 12.6 (6.1), 0-30 180 12.2 (6.3), 1-32 172 −0.55 (−1.64 to 0.54) 0.32
12 months 11.7 (6.7), 1-42 178 10.9 (5.9), 0-26 168 −0.79 (−1.98 to 0.40) 0.19
MFQ† †
Baseline 38.6 (13.7), 1-61 179 41.0 (12.7), 4-62 175
6 months 27.6 (16.5), 0-60 178 28.5 (16.1), 0-60 171 −0.44 (−3.49 to 2.61) 0.78
12 months 24.6 (17.6), 0-62 174 24.4 (16.6), 0-61 170 −1.45 (−4.90 to 1.99) 0.41
SIQ† †
Baseline 88.2 (45.5), 3-172 181 91.3 (42.8), 0-172 177
6 months 59.9 (48.4), 0-174 179 61.5 (45.5), 0-165 171 0.07 (−8.60 to 8.75) 0.99
12 months 49.2 (46.8), 0-179 174 48.3 (42.7), 0-165 169 −2.37 (−11.11 to 6.36) 0.59
*Mean difference between group and usual care adjusted for treatment centre, sex, baseline age, frequency and severity of self-harm, psychosocial
risk, behavioural disorder, and depressive disorder.
†Health of the Nation Outcome Scales for Children and Adolescents ranges from 0 to 52, greater score indicates greater impairment. Mood and
Feelings Questionnaire ranges from 0 to 64; greater score indicates greater symptom severity; clinical diagnostic cut off 28/9. Suicidal Ideation
Questionnaire ranges from 0 to 180; score >40 indicates substantial suicidal ideation.
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In the absence of any difference between treatments
overall, a differential effect of the intervention accord-
ing to a baseline characteristics requires a qualitative
interaction. Pre-specified subgroup analyses consid-
eredthreefactors:antisocialsymptoms,depressivedis-
order,anddeliberateselfpoisoningbeforethe trial.As
summarised in table 4, there was no evidence of a dif-
ferentialtreatmenteffectforthefrequencyandseverity
of self harm at follow-up on any of the three factors.
Economic evaluation
Full resource use data were available for 304 young
people (83% of randomised cases); 151 in group ther-
apy and 153 in routine care. Resource use, reported in
table 5,wassimilar betweengroups. Mostofthe study
participants lived at home with their families for some
period over follow-up; however a substantial propor-
tion spent time living independently, in the care of
socialservices(fosterorresidentialcare),orintempor-
aryaccommodationsuchassheltersandhostels.Those
receiving developmental group psychotherapy spent
considerably more time in residential care than the
routine care group (mean 20 versus eight days). Time
spent in secure care/youth offending institutions was
alsoslightlyhigherforgrouptherapy(meanoneversus
no days).
There was no evidence that developmental group
psychotherapy resulted in any reduction or increase
inhealthserviceuse.Accidentandemergencyservices
were used by almost half of the group. Around a third
of the group spent at least one night as an inpatient.
Almost all the young people in the study had at least
one contact with their local Child and Adolescent
Mental Health Services team or another outpatient
appointment, and the average number of appoint-
ments was 11. Primary care and social work contacts
were also relatively common. Few were admitted to
inpatient psychiatric care, but when they were, it was
for long periods of time.
Totalcostsperyoungpersonarereportedintable 6.
Total costs per young person were higher for develop-
mental group psychotherapy (£21781 [€25232, $
35282])thanroutinecare(£15372),butthisdifference
was not significant (95% CI −1416 to 10782, P=0.132).
Resultsfromthebootstrappedanalyseswereverysimi-
lar and so are not reported here. There was a trend for
total costs per young person to increase over the first
sixmonthsfollowingrandomisation,thentofallbelow
baseline levels over the second six months of follow-
up.Figure2demonstratestheskewednatureofthecost
data with a small number of very costly young people
in both groups. Results of the sensitivity analyses
reported in table 6, suggest that the approach used in
the economic evaluation was robust to changes in
assumptions.
At 12 months’ follow-up, using the full sample
including imputation for missing cases, the proportion
of participants who had not harmed themselves over
the preceding six months was slightly higher for the
group therapy (41.9%) than for routine care (38.9%,
table 2). Thus, the group therapy generated small
improvements in outcomes for large increases in
costs. The incremental cost-effectiveness of the group
therapywas£2020per1%increaseintheproportionof
young people not self harming. The probability that
group therapy is more cost-effective than routine care
ranges from 12% to a maximum of only 28% as will-
ingnesstopayforimprovementsinoutcomeincreases.
Adverse events
Three instances of significant adverse events were
reported during the trial period; all involved self
harm resulting in severe physical injury. Two of the
patients involved were in treatment as usual and one
in the experimental arm. No completed suicide or
other death was recorded during the trial.
DISCUSSION
This is one of the largest randomised trials undertaken
internationally targeting self harm in adolescents or at
any age. We evaluated the effectiveness of adding a
manual based group treatment, developmental group
psychotherapy, for adolescents presenting with
repeated self harm to routine treatment compared
with routine care alone. The majority of patients in
ourstudywereyoungpeopleselfharmingwithorwith-
outselfpoisoningratherthanwithselfpoisoningalone.
The results show an overall improvement in function-
ingover the studyperiodacrossthe wholecohort.The
Table 4 |Subgroup analyses for severity and frequency of self
harm
Ratio of proportional
odds ratios* (95% CI) P
Antisocial symptoms
Frequency
6 months 0.86 (0.30 to 2.45) 0.78
12 months 0.73 (0.26 to 2.09) 0.56
Severity
6 months 1.43 (0.48 to 4.20) 0.52
12 months 0.42 (0.14 to 1.28) 0.13
Depressive disorder
Frequency
6 months 0.97 (0.44 to 2.15) 0.94
12 months 0.91 (0.39 to 2.12) 0.83
Severity
6 months 0.71 (0.31 to 1.61) 0.41
12 months 1.00 (0.43 to 2.33) 1.00
Deliberate self poisoning
Frequency
6 months 1.18 (0.48 to 0.39) 0.69
12 months 1.09 (0.46 to 0.20) 0.85
Severity
6 months 1.03 (0.44 to 0.08) 0.94
12 months 0.90 (0.38 to 0.26) 0.80
*Ratio of proportional odds ratios for the treatment effect adjusting for
centre, sex, baseline age, severity of self harm, psychosocial risk,
behavioural disorder, and depressive disorder, comparing factor present
with factor absent. Ratio equal to 1 represents no treatment with factor
interaction.
RESEARCH
page 8 of 12 BMJ | ONLINE FIRST | bmj.comaddition of group treatment did not significantly
further improve measured primary or secondary out-
comes. Nor did it reduce the range, extent, or cost of
treatmentasusual:indeedtheadditionofdevelopmen-
talgrouppsychotherapytoroutinecarewasassociated
with a trend to higher costs over 12 months’ follow-up
(largely owing to two individuals in developmental
group psychotherapy who spent substantial time in
hospital or in the care of social services over follow-
up—their exclusion in sensitivity analysis did not
alter the main findings of the study). Developmental
group psychotherapy is therefore not, according to
this evidence, a cost-effective addition to the routine
care delivered, and this conclusion held for all values
that a decision maker might be willing to pay for
improvements in outcomes.
The strengths of the study lie in the sample size (we
substantially over-recruited against the target for
power, owing to the high follow-up rate that was
achieved);inthecarefulattentiontoblindingandredu-
cingassessmentbias;in the very low rate of attrition to
end point in a complex group of young people; the
detailed ascertainment of usual treatment; and the
broad economic perspective taken. The experimental
intervention was an open group design adapted to the
needs of the young people. This proved pragmatic in
practice and well accepted by young people, families,
and Child and Adolescent Mental Health Service
teams. There has been substantial demand from
teams to continue the group service locally after the
trialclosure,suggestingthattheinterventionissuitable
for practice within the UK National Health Service.
These findings are at variance with the initial pilot




26 Some of the differences in the results
may come from comparative sample complexity at
baseline in this study and the intervening evolution of
the routine Child and Adolescent Mental Health Ser-
vice treatment for self harm. The initial pilot study
25
took place in a single district Child and Adolescent
Mental Health Service, whereas the subsequent
replication
26 and the current study used wider referral
samples (in the current case from a catchment of
approximately five million); referrals tended towards
high baseline severity, complexity, and chronicity. A
related feature of this study was the very high level of
continuinguseofChildandAdolescentMentalHealth
Services in the year to follow-up (in 86% of the cohort,
with a relatively high frequency of appointments). In
addition,overaquarterofthesamplehadcontactwith
acommunitypsychiatricnurseandtherewasextensive
use of general practitioner (in 77% of the sample) and
voluntary sector (in 20% of the sample) services. This
high use of health resources suggests that, in the geo-
graphical area of the studyat least, these young people
receive a significant amount of ongoing help—a pat-
tern that replicates the recent Australian findings and
may also reflectthe cumulative impact of researchand
service development around adolescent self harm in
the trial area in recent years. A limitation to inferences

















5.2 (37.1) 3 0.8 (8.3) 1
Foster care (nights) 1.5 (16.1) 2 4.0 (30.1) 2
Residential care
(nights)
7.8 (43.7) 5 20.0 (73.3) 8
Shelter/refuge
(nights)
3.0 (19.3) 3 6.0 (34.7) 3
Bed and breakfast/
hotel (nights)




9.0 (29.1) 12 11.6 (42.0) 17
Inpatient medical
(days)
2.2 (9.3) 26 1.2 (3.3) 26
CAMHS/outpatient
(appointments)
9.5 (13.2) 89 12.8 (20.7) 83
Day patient
(appointments)









3.0 (3.5) 76 3.1 (3.5) 78
Practice nurse
(contact)




3.8 (10.1) 28 2.6 (7.7) 28
Health visitor
(contact)
1.7 (8.8) 6 0.2 (1.9) 2
Psychologist(contact) 0.4 (2.0) 6 0.1 (1.6) 1
Counsellor (contact) 0.4 (4.2) 2 0.1 (0.4) 2
Family therapist
(contact)
0.2 (1.0) 4 0.1 (0.5) 2
Drug and alcohol
worker (contact)
0.1 (1.1) 1 0.5 (3.8) 2
Dietitian (contact) 0.0 (0.2) 1 0.0 (0.0) 0
Family planning
service (contact)
0.3 (1.3) 6 0.2 (1.2) 5
Physiotherapist
(contact)
0.0 (0.1) 1 0.0 (0.1) 1
Occupational
therapist (contact)
0.0 (0.0) 0 0.1 (1.8) 1
Walk-in centre
(attendances)
0.0 (0.2) 1 0.0 (0.2) 1
Social worker
(contact)
2.0 (4.8) 33 2.4 (6.4) 25
Support worker
(contact)
1.5 (6.2) 11 1.8 (7.4) 11
School doctor
(contact)
0.0 (0.1) 1 0.0 (0.0) 0
School nurse
(contact)
1.2 (6.1) 14 0.2 (0.9) 6
Voluntary sector
services (contacts)
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level ofserviceusewould generalisetoother childand
adolescent mental health service contexts.
The design of the trial did not allow testing between
explanatory hypotheses about the cause of the overall
cohort improvement; whether, for instance, it was
related to a regression to the mean or to a rather better
natural history of adolescent self harm than is often
supposed. Few long term follow-up studies of adoles-
cent self harm have been done, with most studies con-
centrating on specific short outcomes on suicide and
repetition. Harrington and colleagues
19 followed up a
sampleofpatientswhoparticipatedinafamilytherapy
intervention after a single overdose compared with
matched controls identified through general practi-
tioner surgeries, and found that 70% were no longer




58 and our results suggest this decrease may
begin before this age. Alternatively, the overall
improvement could relate to the considerable amount
of routine ascertainment and care demonstrated in
both arms in this sample; studies of adult self harm
have suggested that even a small amount of contact,
forinstancewithpostcards,canhelppreventrepetition
in some individuals
59—although overall evidence for
this is also mixed.
60
The evidence from the trial does not therefore lend
support to the addition of developmental group psy-
chotherapy to current routine care for the Child and
Adolescent Mental Health Services treatment of ado-
lescent self harm. However, the detailed evaluation of
serviceusedoeshighlightthepotentialeffectofarange
ofcurrentservicesonselfharm,andraisesquestionsas
to which of these are most effective. Follow-up of this
well characterised cohort would add useful informa-
tion about the natural history of repeated self harming
behaviourinadolescence;comparativestudiesinareas
with different patterns of service use would illuminate
the potential effect of routine care in this study. Self
harminadolescenceremainsaverychallengingpublic
health problem that deserves continuing research and
clinical efforts towards its alleviation.
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Mean (SD) % Mean (SD) %
Mainstream school
(months)
7.1 (5.1) 62 6.0 (5.0) 66
Private day school
(months)
0.3 (1.5) 3 0.4 (1.9) 5
College (months) 1.4 (2.8) 23 1.2 (2.5) 22
Residential school
(months)
0.0 (0.0) 0 0.2 (1.1) 3
LD/EBD school
(months)
0.1 (1.0) 1 0.0 (0.5) 1
Pupil referral unit
(months)
0.6 (2.2) 8 0.4 (1.8) 6
Hospital school
(months)
0.6 (2.1) 8 0.8 (2.5) 11
Home tuition
(months)
0.1 (0.4) 3 0.1 (0.8) 3
Classroom support
(sessions)
0.9 (9.7) 2 0.1 (0.7) 1
Education welfare
officer (contact)
0.2 (0.8) 9 0.3 (2.3) 5
Education
psychologist (contact)
0.0 (0.4) 2 0.1 (0.7) 1
Education counsellor
(contact)
0.5 (2.7) 6 1.1 (6.2) 6
Mentor (contact) 3.4 (15.1) 12 2.3 (11.2) 8




0.6 (2.7) 7 0.9 (4.0) 9
Solicitor (contact) 0.3 (1.7) 5 0.1 (0.8) 4
Police (contact) 1.6 (6.8) 37 1.8 (5.3) 37




0.0 (0.0) 0 0.9 (8.3) 2
Police custody/
remand (sessions)
0.1 (0.7) 1 0.1 (1.2) 2
CAMHS=child and adolescent mental health services. LD/EBD=learning
















































Fig 2 | Box and whisker plot of total cost per participant pre-
baseline, 6 months, and 12 months from baseline by
randomised group (£)
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*Conversion rates at time of analysis: £ to €, 1.4629; £ to $, 1.8189
(source: www.bankofengland.co.uk/statistics/index.htm).
†Adjusted for treatment centre, sex, baseline age, frequency and severity
of self harm, stability of family situation, behavioural disorder,
depressive disorder, and baseline cost.
WHAT THIS PAPER ADDS
What is already known
Self harm is a major public health problem in many countries but uncertainty remains about
which forms of treatment are most effective.
Studies to date have been methodologically limited and few have specifically assessed self
harm in adolescents
What this study adds
We identified substantial involvement of mental health and primary care services in care for
patients who self harmed in the geographical area of the study, along with a considerable
symptom improvement across both arms of the trial at one year’sf o l l o w - u p .
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